CHELSEA THERAPEUTICS INTL LT's ticker is and the CUSIP is 163428955. A total of 3 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $0 | -100.0% | 1,106,300 | +492.2% | 0.00% | -100.0% |
| Q1 2014 | $1,031,000 | +47.1% | 186,800 | +18.2% | 0.02% | +54.5% |
| Q4 2013 | $701,000 | +7.2% | 158,000 | -27.7% | 0.01% | -15.4% |
| Q3 2013 | $654,000 | +144.0% | 218,600 | +87.3% | 0.01% | +85.7% |
| Q2 2013 | $268,000 | – | 116,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,509 | $1,113,000 | 0.07% |
| GROUP ONE TRADING, L.P. | 158,000 | $701,000 | 0.01% |
| Citadel Advisors | 23,800 | $105,000 | 0.00% |